News & Events


Recent Firm Activities and Highlights

COTA
BMP Invests in COTA
12.20.16
Boston Millennia Partners Invests in Cota, Inc. Boston, MA, December 2016, Boston Millennia Partners is pleased to announce its investment in Cota, Inc. as part of an $18 million growth equity round. Cota is a New York City based cancer outcomes and data tracking company that uses a patented digital classification system to assess patient results on specific treatment protocols. Cota’s customers include pharmaceutical companies, healthcare providers and insurance companies. The company has partnerships with several major pharmaceutical companies in the U.S. including Novartis and Celgene, and with data provider Foundation Medicine. The company has received strategic investments from Novartis, Celgene, Foundation Medicine and Horizon Healthcare. Read Full Release
Season’s Greetings from BMP
12.19.16
We wish you a very happy, healthy and safe holiday season! Read Full Release
COTA
PE Hub Network on BMP invests in Cota
12.15.16
BOSTON–(BUSINESS WIRE)–December 15, 2016–Boston Millennia Partners is pleased to announce its investment in Cota, Inc. as part of an $18 million growth equity round. Cota is a New York City based cancer outcomes and data tracking company that uses a patented digital classification system to assess patient results on specific treatment protocols. Cota’s customers include pharmaceutical companies, healthcare providers and insurance companies. The company has partnerships with several major pharmaceutical companies in the U.S. including Novartis and Celgene, and with data provider Foundation Medicine. The company has received strategic investments from Novartis, Celgene, Foundation Medicine and Horizon Healthcare. Read Full Release
Collegium Announces the Addition of Xtampza ER to Express Scripts’ Formulary
12.15.16
Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it has finalized its contract with Express Scripts, the largest pharmacy benefits management (PBM) in the United States. Pursuant to the contract, Xtampza ER is covered on the 2017 Express Scripts’ National Preferred Formulary. Read Full Release
Collegium Pharmaceutical
Jeffries Key Takeaway: Another Formulary Win Further Positions Xtampza for a Potential 1H17 Inflection
12.15.16
COLL announced another formulary “win” for Xtampza following successful contracting with ESRX, the largest US pharmacy benefits manager (PBM). Starting January 1, 2017, Xtampza will be added to ESRX’s formulary as a preferred brand with access to another 28M commercial lives. Based on steady progress with the launch and managed care wins, we continue to believe that Xtampza Rxs are positioned for an inflection in 1H17 and see the drug as a $400M+ peak product. Read Full Release
Boston Millennia Parters
BC Platforms to Partner with Microsoft
11.28.16
BC Platforms, a world leader in genomic data management solutions, today announced that it will collaborate with Microsoft to provide integrated genomic data management solutions in the cloud to Codigo46. Codigo46, an emerging Mexican company, is building and managing the largest biobank in Latin-America in co-operation with Mexican health and research authorities. Codigo46 will genotype one million Mexican subjects in the next three years for the purpose of delivering personalized medicine benefits to patients. BC Platforms signed a partnership with Codigo46 in July 2016. Read Full Release
Boston Millennia Parters
BMP Invests in BC Platforms
11.24.16
The investment is a significant milestone in BC Platforms’ success and growth in North America as we roll-out our US expansion with headquarters in Boston. The Boston area boasts nearly 30,000 scientists and other workers directly involved in biotech, pharmaceutical and clinical research, the highest concentration of life-science research workers in the U.S. We are glad to have BMP as a partner to facilitate our ambitious development goals in the No. 1 U.S. life science hub. Read Full Release
Boston Millennia Parters
Dana Callow to Speak on The State of The VC Market Panel
11.17.16
ACG Boston's regular networking breakfast returns to Serafina in Boston's financial district. Open to all, the Networking Breakfast is ACG Boston's signature event, where M&A professionals come to network and hear industry experts share their outlook, opinions, successes and failures. Join New England's M&A community on November 17 to hear a panel discussion on the current state of the VC market -- how the industry has evolved and where it's headed in the future. Read Full Release
Boston Millennia Parters
Will value-based payment initiatives continue under Trump?
11.11.16
President-elect Donald Trump's promise to dismantle the Affordable Care Act is unlikely to also undo widespread efforts to nudge the U.S. healthcare system toward value-based payment, including experiments devised by the ACA-funded CMS Innovation Center. Read Full Release
Boston Millennia Parters
3Derm October Newsletter
10.31.16
It's that time of year in Boston when you have 75 degree weekends followed immediately by 35 degree Mondays. We get it, Beantown is not an ideal destination at the moment. HOWEVER, this week our team will be opening up our office to advisors, investors, and other industry minds to hold a week of BrainTrust™ brainstorming sessions that cover Product Strategy, Workflow and Operations, Future Technology, and Marketing and Productizing. Video conference attendees are welcome. Read Full Release